CM
COLL icon

Castleark Management’s Collegium Pharmaceutical COLL Stock Holding History

Castleark Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-292,878
Closed -$6.99M – 385
2018
Q2 		$6.99M Buy
292,878
+70,820
+32% +$1.74M 0.22% 153
2018
Q1 		$5.67M Buy
+222,058
New +$5.29M 0.18% 168

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Castleark Management's COLL Position: Q3 2018 in Review

Castleark Management sold out of Collegium Pharmaceutical (COLL) in Q3 2018, closing a stake of 292,878 shares — an estimated $6.99M sold.

Castleark Management first reported a position in COLL in Q1 2018 and held it in 2 quarters. The position peaked at $6.99M in Q2 2018. 124 funds tracked by Wall St. Rank hold COLL as of Q3 2018.

  • Castleark Management reported no remaining Collegium Pharmaceutical position as of Q3 2018 after selling out during the quarter.
  • Castleark Management sold 292,878 Collegium Pharmaceutical shares in Q3 2018, an estimated $6.99M.
  • Castleark Management first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 2 quarters.
  • Castleark Management's Collegium Pharmaceutical position peaked at $6.99M in Q2 2018.
  • 124 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2018.

Based on Castleark Management's 13F filing for Q3 2018, filed 15 Nov 2018.